Evidence map›Paper›PMID 36855089›Full record

ArticleBMC anesthesiology2023

Influence of opioid analgesia type on circulating tumor cells in open colorectal cancer surgery (POACC-1): study protocol for a prospective randomized multicenter controlled trial.

Emil Berta, Josef Srovnal, Petr Dytrych, Jan Bruthans, Jitka Ulrichova, Petr Prasil, Lubomir Vecera, Tomas Gabrhelik, Benjamin Tolmaci, Josef Dusa and 7 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC anesthesiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03700411 (Influence of Peri-operative Opioid Analgesia on Circulating Tumor Cells in Patients Undergoing Open Colorectal Cancer Surgery - Multi-center, Randomized Clinical Trial), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03700411 phase4completednot on this map

Influence of Peri-operative Opioid Analgesia on Circulating Tumor Cells in Patients Undergoing Open Colorectal Cancer Surgery - Multi-center, Randomized Clinical Trial

TypeinterventionalSponsorThe Institute of Molecular and Translational Medicine, Czech RepublicRan2019 to 2023Enrolled125ConditionsColorectal Cancer, Circulating Tumor CellArmsMorphine, Piritramid, Epidural
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Emil Berta *Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky, University and University Hospital in Olomouc, Olomouc, Czech Republic.
Josef Srovnal *Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky, University and University Hospital in Olomouc, Olomouc, Czech Republic.
Petr DytrychDepartment of Anesthesiology and Intensive Medicine, General University Hospital and First Medical Faculty of the Charles University, Prague, Czech Republic.
Jan BruthansDepartment of Anesthesiology and Intensive Medicine, General University Hospital and First Medical Faculty of the Charles University, Prague, Czech Republic.
Jitka UlrichovaDepartment of Anesthesiology and Intensive Medicine, General University Hospital and First Medical Faculty of the Charles University, Prague, Czech Republic.
Petr PrasilDepartment of Anesthesiology, Landesklinikum Amstetten, Amstetten, Austria.
Lubomir VeceraDepartment of Anesthesiology and Intensive Medicine, Tomas Bata Regional Hospital in Zlin, Zlin, Czech Republic.
Tomas GabrhelikDepartment of Anesthesiology and Intensive Medicine, Tomas Bata Regional Hospital in Zlin, Zlin, Czech Republic.
Benjamin TolmaciDepartment of Surgery, Tomas Bata Regional Hospital in Zlin, Zlin, Czech Republic.
Josef DusaDepartment of Surgery, Tomas Bata Regional Hospital in Zlin, Zlin, Czech Republic.
Jan MacaDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
Michelle MazancovaDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
Filip HaidukDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
Martin KutejDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
Peter IhnatDepartment of Surgery, University Hospital Ostrava, Ostrava, Czech Republic.
Pavel MichalekDepartment of Anesthesiology and Intensive Medicine, General University Hospital and First Medical Faculty of the Charles University, Prague, Czech Republic. pafkamich@yahoo.co.uk.ORCID 0000-0001-8119-5927
Marian HajduchInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky, University and University Hospital in Olomouc, Olomouc, Czech Republic. marian.hajduch@upol.cz.
Charles University · CZMasaryk University · CZInstitute of Molecular and Translational Medicine · CZUniversity Hospital Olomouc · CZUniversity of Ostrava · CZNorwegian Mapping Authority · NOUniversity Hospital Ostrava · CZ

Funding

Ministerstvo Zdravotnictví Ceské Republiky NV-18-03-00470
6 · The paper itself

Abstract

backgroundOpioids and epidural analgesia are a mainstay of perioperative analgesia but their influence on cancer recurrence remains unclear. Based on retrospective data, we found that cancer recurrence following colorectal cancer surgery correlates with the number of circulating tumor cells (CTCs) in the early postoperative period. Also, morphine- but not piritramide-based postoperative analgesia increases the presence of CTCs and shortens cancer-specific survival. The influence of epidural analgesia on CTCs has not been studied yet.

methodsWe intend to enroll 120 patients in four centers in this prospective randomized controlled trial. The study protocol has been approved by Ethics Committees in all participating centers. Patients undergoing radical open colorectal cancer surgery are randomized into epidural, morphine, and piritramide groups for perioperative analgesia. The primary outcome is the difference in the number of CTCs in the peripheral blood before surgery, on the second postoperative day, and 2-4 weeks after surgery. The number of CTCs is measured using molecular biology methods. Perioperative care is standardized, and relevant data is recorded. A secondary outcome, if feasible, would be the expression and activity of various receptor subtypes in cancer tissue. We intend to perform a 5-year follow-up with regard to metastasis development. DISCUSSION: The mode of perioperative analgesia favorably affecting cancer recurrence would decrease morbidity/mortality. To identify such techniques, trials with long-term follow-up periods seem suboptimal. Given complex oncological therapeutic strategies, such trials likely disable the separation of perioperative analgesia effects from other factors. We believe that early postoperative CTCs presence/dynamics may serve as a sensitive marker of various perioperative interventions´ influences on cancer recurrence. Importantly, it is unbiased to the influence of long-term factors and minimally invasive. Analysis of opioid/cannabinoid receptor subtypes in cancer tissue would improve understanding of underlying mechanisms and promote personalization of treatment. We are not aware of any similar ongoing studies. TRIAL REGISTRATION NUMBER: NCT03700411, registration date: October 3, 2018. STUDY STATUS: recruiting.

Indexed as

Analgesia, EpiduralColorectal NeoplasmsNeoplastic Cells, CirculatingAnalgesics, OpioidHumansMorphineMulticenter Studies as TopicNeoplasm Recurrence, LocalProspective StudiesRandomized Controlled Trials as TopicRetrospective StudiesAnalgesics, OpioidMorphineCancer recurrenceCirculating tumor cellsColorectal cancerColorectal surgeryEpiduralMorphinePerioperative analgesiaPiritramide

Identifiers

PMID36855089
PMCPMC9972763
OpenAlexW4322719739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.